FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 19 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $173,000 | -73.3% | 35,037 | -39.9% | 0.01% | -76.3% |
| Q4 2016 | $648,000 | -65.3% | 58,338 | -71.1% | 0.04% | -45.7% |
| Q3 2016 | $1,866,000 | +15.8% | 201,564 | -20.6% | 0.07% | -16.7% |
| Q2 2016 | $1,611,000 | -5.1% | 253,706 | -2.6% | 0.08% | -1.2% |
| Q1 2016 | $1,698,000 | -12.2% | 260,400 | +9.2% | 0.08% | -19.8% |
| Q4 2015 | $1,933,000 | +8.4% | 238,400 | -2.0% | 0.11% | +45.2% |
| Q3 2015 | $1,784,000 | -1.1% | 243,361 | +38.3% | 0.07% | +10.6% |
| Q2 2015 | $1,804,000 | +1170.4% | 176,000 | +1050.3% | 0.07% | +1000.0% |
| Q1 2015 | $142,000 | -87.6% | 15,300 | -90.6% | 0.01% | -83.3% |
| Q4 2014 | $1,145,000 | -22.5% | 163,300 | -39.8% | 0.04% | -36.8% |
| Q3 2014 | $1,478,000 | – | 271,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
| GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
| Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
| Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
| DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
| RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
| SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
| Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
| Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
| NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |